Combination Of Talazoparib And Enzalutamide In The Treatment Of Metastatic Castration-Resistant Prostate Cancer - EP4593828
The patent EP4593828 was granted to Pfizer on Aug 6, 2025. The application was originally filed on Sep 29, 2023. The patent is currently recorded with a legal status of "Pending".
EP4593828
- Filing Date
- Sep 29, 2023
- Status
- Pending
- Grant Date
- Aug 6, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents